ORAGENICS INC — Director's Dealing 2018

Oct 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2018-09-27

Reporting Person: Joslyn Alan (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-27	Employee Stock Option (Right to Buy)	$0.73	A	400000	Acquired	2028-09-27	Common Stock (400000)	Direct

Footnotes

F1: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest immediately, the second third of the options vest on the first anniversary of the grant date and the final third vest on the second anniversary of the grant date. The option exercise price is the closing price on the date of the grant, September 27, 2018.